Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

The study maps immune changes in mice with alopecia areata to better understand and treat the disease in humans.

Immune activities and specific genes are important in male pattern baldness.

Antioxidant nanoparticles show promise for treating inflammatory diseases but need more research for safe and effective use.

MG53 helps reduce skin damage caused by nitrogen mustard.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Generalized trichoepitheliomas with hair loss may indicate myasthenia gravis.

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.

Two men experienced hair regrowth while being treated with immune globulin for other health issues, but there were also side effects.

Thymus-derived Tregs, not peripherally-derived Tregs, primarily regulate type 1 diabetes in the NOD mouse model.

Antituberculous drugs improved symptoms in a woman with lupus and myositis.

Malassezia fungi may contribute to hair loss and inflammation in androgenetic alopecia.

A rare genetic condition can mimic symptoms of other diseases, making diagnosis challenging.

Alopecia can be caused by multicentric reticulohistiocytosis.

AMH is a reliable marker for diagnosing PCOS.

The humanized AA mouse model is better for testing new alopecia areata treatments.

Researchers found a new gene variant linked to a rare bone disease, which doesn't always cause symptoms in carriers.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

A specific genetic change is linked to mental disorders, intellectual disability, and possibly autoimmune disease in a family.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

High levels of IL6 and CRP, and low levels of vitamin D, might be indicators of alopecia areata.

Frontal Fibrosing Alopecia might be an autoimmune disease.

Bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata may share immune-related causes.

Prior infections reduced alopecia areata development in mice.

CD4 T cells can cause alopecia areata by activating CD8 T cells to attack hair follicles.

A simple test can help diagnose a rare bruising disorder after ruling out other causes.